CD44 and cyclic hematopoiesis: Transgenic mice expressing active, cardiac-specific NHE1 showed alterations in gene expression that led to both CH and an upregulation of OPN as well as its related molecules, including fibronectin, CD44, integrin receptors, MMPs, and signaling kinases [42].